Prithviraj Bose, MD

Dr. Prithviraj Bose is a hematologist-oncologist and Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center, where he focuses on myeloproliferative neoplasms (MPNs) and chronic lymphocytic leukemia. After earning his medical degree from Calcutta Medical College in 2001, he completed his training in the U.S., including a fellowship in hematology/oncology at the University of Oklahoma. He served on faculty at Virginia Commonwealth University from 2010 to 2015 before joining MD Anderson.

Dr. Bose leads clinical trials in myelofibrosis, essential thrombocythemia, and systemic mastocytosis. He serves on the NCCN MPN panel and has published extensively in The New England Journal of Medicine, Blood, and Cancer Cell. A recipient of ASH’s Clinical Research Training Institute honor, he is also a former editor-in-chief of Drug Target Insights and currently serves on the editorial board of Hematology.